Загрузка...
Oridonin Sensitizes Hepatocellular Carcinoma to the Anticancer Effect of Sorafenib by Targeting the Akt Pathway
BACKGROUND: Oridonin is the core bioactive component of Rabdosia rubescens, a traditional Chinese herbal medicine used in the treatment of hepatoma. Sorafenib, a targeted therapeutic agent for advanced hepatocellular carcinoma (HCC), has recently been shown to exert limited clinical effects. However...
Сохранить в:
| Опубликовано в: : | Cancer Manag Res |
|---|---|
| Главные авторы: | , , , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Dove
2020
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7494228/ https://ncbi.nlm.nih.gov/pubmed/32982405 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/CMAR.S257482 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|